Literature DB >> 10845408

Ambulatory use of parenteral antibacterials: contemporary perspectives.

J E Leggett1.   

Abstract

Outpatient parenteral antimicrobial therapy (OPAT) offers increased patient comfort and convenience in appropriately selected patients who require parenteral antibacterial therapy, as well as opportunity for cost savings. Home-based programmes, with drugs being administered by the patient or the caregiver, have become the norm in the USA. Choice of drugs for OPAT is based on antimicrobial spectrum, dosage regimen, drug stability, toxicity profile, and cost. Over the past decade, availability of sophisticated programmable pumps has allowed a wider range of antimicrobial agents to be used in the ambulatory setting. The most popular antibacterial agents in OPAT programmes in the USA are vancomycin and beta-lactams.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845408     DOI: 10.2165/00003495-200059003-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  59 in total

1.  Home intravenous anti-infective therapy (HIVAT): do the benefits outweigh the risks?

Authors:  D N Williams
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

2.  Outpatient antimicrobial protocol for febrile neutropenia: a nonrandomized prospective trial using ceftriaxone, amikacin, and oral adjuvant agents.

Authors:  S Sahu; A Bapna; S K Pai; C N Nair; P A Kurkure; S H Advani
Journal:  Pediatr Hematol Oncol       Date:  1997 May-Jun       Impact factor: 1.969

3.  Intramuscular ceftriaxone in home parenteral therapy.

Authors:  T A Russo; S Cook; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

4.  Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance.

Authors:  J Blaser; B B Stone; M C Groner; S H Zinner
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

5.  Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects.

Authors:  J M Wolter; S D Bowler; P J Nolan; J G McCormack
Journal:  Eur Respir J       Date:  1997-04       Impact factor: 16.671

6.  Practice guidelines for community-based parenteral anti-infective therapy. ISDA Practice Guidelines Committee.

Authors:  D N Williams; S J Rehm; A D Tice; J S Bradley; A C Kind; W A Craig
Journal:  Clin Infect Dis       Date:  1997-10       Impact factor: 9.079

7.  Safety, efficacy, and cost savings in an outpatient intravenous antibiotic program.

Authors:  D N Williams; D Bosch; J Boots; J Schneider
Journal:  Clin Ther       Date:  1993 Jan-Feb       Impact factor: 3.393

8.  Treatment of skin and soft-tissue infections utilizing an outpatient parenteral drug delivery device: a multicenter trial. HIAT Study Group.

Authors:  D M Poretz
Journal:  Am J Med       Date:  1994-08-15       Impact factor: 4.965

Review 9.  Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA.

Authors:  W A Craig
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-07       Impact factor: 3.267

10.  Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.

Authors:  A Forrest; D E Nix; C H Ballow; T F Goss; M C Birmingham; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

View more
  1 in total

1.  Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program.

Authors:  Lore Thijs; Charlotte Quintens; Lotte Vander Elst; Paul De Munter; Melissa Depypere; Willem-Jan Metsemakers; Georges Vles; Astrid Liesenborghs; Jens Neefs; Willy E Peetermans; Isabel Spriet
Journal:  Antibiotics (Basel)       Date:  2022-05-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.